CY1121241T1 - Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων - Google Patents

Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Info

Publication number
CY1121241T1
CY1121241T1 CY20181100951T CY181100951T CY1121241T1 CY 1121241 T1 CY1121241 T1 CY 1121241T1 CY 20181100951 T CY20181100951 T CY 20181100951T CY 181100951 T CY181100951 T CY 181100951T CY 1121241 T1 CY1121241 T1 CY 1121241T1
Authority
CY
Cyprus
Prior art keywords
solvent
particles
mixing method
pharmaceutical ingredients
coated
Prior art date
Application number
CY20181100951T
Other languages
Greek (el)
English (en)
Inventor
Rajesh N. Dave
Daniel TO
Maxx CAPECE
Original Assignee
New Jersey Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Institute Of Technology filed Critical New Jersey Institute Of Technology
Publication of CY1121241T1 publication Critical patent/CY1121241T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20181100951T 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων CY1121241T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/651,977 US9107851B2 (en) 2012-10-15 2012-10-15 Solventless mixing process for coating pharmaceutical ingredients
PCT/US2013/064058 WO2014062444A1 (en) 2012-10-15 2013-10-09 Solventless mixing process for coating pharmaceutical ingredients

Publications (1)

Publication Number Publication Date
CY1121241T1 true CY1121241T1 (el) 2020-05-29

Family

ID=49474713

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100951T CY1121241T1 (el) 2012-10-15 2018-09-13 Μεθοδος αναμειξης χωρις διαλυτη για την επικαλυψη φαρμακευτικων συστατικων

Country Status (16)

Country Link
US (1) US9107851B2 (enExample)
EP (1) EP2906205B1 (enExample)
JP (1) JP6159504B2 (enExample)
CN (1) CN104853751B (enExample)
AR (1) AR093013A1 (enExample)
BR (1) BR112015008285B1 (enExample)
CY (1) CY1121241T1 (enExample)
DK (1) DK2906205T3 (enExample)
ES (1) ES2688889T3 (enExample)
HR (1) HRP20181463T1 (enExample)
HU (1) HUE039772T2 (enExample)
PL (1) PL2906205T3 (enExample)
PT (1) PT2906205T (enExample)
RS (1) RS57918B1 (enExample)
SI (1) SI2906205T1 (enExample)
WO (1) WO2014062444A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016011412A1 (en) 2014-07-17 2016-01-21 Ada Technologies, Inc. Extreme long life, high energy density batteries and method of making and using the same
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
US10217571B2 (en) 2015-05-21 2019-02-26 Ada Technologies, Inc. High energy density hybrid pseudocapacitors and method of making and using the same
US12401042B2 (en) 2015-06-01 2025-08-26 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US12027661B2 (en) 2015-06-01 2024-07-02 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US11996564B2 (en) 2015-06-01 2024-05-28 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
US10692659B2 (en) 2015-07-31 2020-06-23 Ada Technologies, Inc. High energy and power electrochemical device and method of making and using same
JP7069538B2 (ja) * 2016-12-05 2022-05-18 マルボシ酢株式会社 食酢含有飲料組成物
US11024846B2 (en) 2017-03-23 2021-06-01 Ada Technologies, Inc. High energy/power density, long cycle life, safe lithium-ion battery capable of long-term deep discharge/storage near zero volt and method of making and using the same
WO2019009335A1 (ja) * 2017-07-04 2019-01-10 村上 正裕 微粒子の製造方法及び微粒子
BR112021016485A2 (pt) * 2019-02-22 2021-10-13 Catalent U.K. Swindon Zydis Limited Minimização de aglomeração de material de revestimento de partícula de fármaco durante armazenamento para estabilizar tempos de desintegração de produtos farmacêuticos
AR118418A1 (es) 2019-02-22 2021-10-06 Catalent Uk Swindon Zydis Ltd Conservación de partículas ifa revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspensión acuosa
CN113490486B (zh) 2019-02-22 2025-10-17 康特伦英国斯温顿捷迪斯有限公司 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣
CA3129383A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
US20210009767A1 (en) * 2019-07-11 2021-01-14 International Flavors & Fragrances Inc. Solventless particle coating via acoustic mixing
US12285731B2 (en) 2019-09-12 2025-04-29 United States Of America, As Represented By The Secretary Of The Army Acoustic mixing system for creating propellant mixture
MX2023001004A (es) * 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto.
CN120053389A (zh) * 2025-02-25 2025-05-30 江苏亚邦爱普森药业有限公司 一种含有替米沙坦药物的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628945A (en) 1992-08-03 1997-05-13 Riman; Richard E. Multicomponent powder mixing process and compositions produced thereby
WO1994015374A1 (fr) * 1992-12-25 1994-07-07 Tdk Corporation Element secondaire au lithium
US5769917A (en) * 1996-12-09 1998-06-23 Belko; William C. Process for producing low shrink ceramic bodies
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DE10062176A1 (de) * 2000-12-14 2002-07-04 Wacker Polymer Systems Gmbh Polyvinylacetal-gepfropfte Polymerisate
US8163114B2 (en) 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
DE102004059792A1 (de) * 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US20060210694A1 (en) * 2005-03-18 2006-09-21 Chappell Rulon A Anti-caking agents and methods
US7862848B2 (en) 2005-08-03 2011-01-04 The University Of Western Ontario Direct coating solid dosage forms using powdered materials
WO2011155451A1 (ja) 2010-06-08 2011-12-15 学校法人神戸学院 コーティング粒子及びコーティング粒子の製造方法
GB201205632D0 (en) 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them

Also Published As

Publication number Publication date
PL2906205T3 (pl) 2019-03-29
CN104853751B (zh) 2018-06-22
BR112015008285B1 (pt) 2022-11-16
JP2015533162A (ja) 2015-11-19
EP2906205B1 (en) 2018-06-13
CN104853751A (zh) 2015-08-19
US20140106059A1 (en) 2014-04-17
HRP20181463T1 (hr) 2018-12-14
US9107851B2 (en) 2015-08-18
JP6159504B2 (ja) 2017-07-05
BR112015008285A2 (pt) 2017-07-04
DK2906205T3 (en) 2018-09-24
WO2014062444A1 (en) 2014-04-24
HUE039772T2 (hu) 2019-02-28
RS57918B1 (sr) 2019-01-31
AR093013A1 (es) 2015-05-13
EP2906205A1 (en) 2015-08-19
SI2906205T1 (sl) 2018-12-31
PT2906205T (pt) 2018-11-07
ES2688889T3 (es) 2018-11-07

Similar Documents

Publication Publication Date Title
Mahmoudi et al. Interaction of stable colloidal nanoparticles with cellular membranes
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1125595T1 (el) Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης
IL263274A (en) Covalently adapted surfaces, kits and methods for their production and uses
EP3436482A4 (en) ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND METHODS
BR112015008285A2 (pt) processo para preparar uma formulação farmacêutica particulada
BR112018010743A8 (pt) ?método para fabricação de um pó farmacêutico formulado, e, pó farmacêutico formulado?
AU2018348359A8 (en) Extended release pharmaceutical formulation and methods of treatment
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
CL2016001895A1 (es) Compuestos
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
HK1216083A1 (zh) 经动脉的药物递送
EP3592746A4 (en) TYK2 INHIBITORS, THEIR USES AND THEIR PRODUCTION PROCESSES
CY1123202T1 (el) Σκευασμα υδροκορτιζονης ελεγχομενης απελευθερωσης
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
EP3277806A4 (en) Methods of forming nanostructures using self-assembled nucleic acids, and nanostructures thereof
EP3558384A4 (en) BIOCOMPATIBLE AND HYDROPHILIC POLYMER CONJUGATE INTENDED FOR THE TARGETED ADMINISTRATION OF AN AGENT
WO2014153495A3 (en) Novel stat3 inhibitors
GB2528421A (en) Methods and processes for application of drug delivery polymeric coatings
EP3595638A4 (en) PHARMACEUTICAL COMPOSITIONS WITH HIGH DRUG LOADS BASED ON MEDIUM-CHAIN TRIGLYCERIDES AND RELATED METHODS
PL3380526T3 (pl) Przyjazny dla środowiska sposób przygotowywania nanocelulozy i jej pochodnych
PH12014502834A1 (en) Pharmaceutical form for extended release of active substances
WO2015095659A3 (en) Indirubin solid dispersion composition
MX394131B (es) Partículas revestidas y sus usos.
MX390441B (es) Formulaciones liquidas de fosfaplatino.